Ward Keith Wayne

Chief Development Officer at REATA PHARMACEUTICALS INC · on record since Dec 8, 2016
Director at Skye Bioscience, Inc. · on record since Dec 16, 2021

Insider trading activity of Ward Keith Wayne

Transactions on record: 64; since May 26, 2016

Open-market buys: 0

Open-market sells: 13; $6.9M

Companies traded: 2; last filing Mar 4, 2024

Figures computed from official regulatory filings — .

Companies where Ward Keith Wayne has traded

Skye Bioscience, Inc.5 tx · Mar 4, 2024
REATA PHARMACEUTICALS INC59 tx · $8.2M · Feb 27, 2019

Track record of Ward Keith Wayne

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Ward Keith Wayne

Co-insiders of Ward Keith Wayne

5AM CO-INVESTORS II LPSkye Bioscience, Inc.
5AM Partners II, LLCSkye Bioscience, Inc.
5AM Partners VII, LLCSkye Bioscience, Inc.
5AM Ventures II LPSkye Bioscience, Inc.
5AM Ventures VII, L.P.Skye Bioscience, Inc.
AbbVie Inc.REATA PHARMACEUTICALS INC
Anand BhaskarREATA PHARMACEUTICALS INC
Arora Puneet S.Skye Bioscience, Inc.
Arsenault Kaitlyn MelanieSkye Bioscience, Inc.
Bass James EdwardREATA PHARMACEUTICALS INC
Berecz ElizabethSkye Bioscience, Inc.
BIOGEN IDEC INCREATA PHARMACEUTICALS INC
Bir Dawn CarterREATA PHARMACEUTICALS INC
Castellanos ElaineREATA PHARMACEUTICALS INC
Cesario Douglas ASkye Bioscience, Inc.
Charles E. Gale Fidelity Rollover IRAREATA PHARMACEUTICALS INC
Charles Henry Rose 2001 TrustREATA PHARMACEUTICALS INC
Charych Deborah H.Skye Bioscience, Inc.
CPMG IncREATA PHARMACEUTICALS INC
DALESANDRO MARGARETSkye Bioscience, Inc.
Desai Antal RohitREATA PHARMACEUTICALS INC
DHILLON AVTAR SSkye Bioscience, Inc.
DHILLON PUNITSkye Bioscience, Inc.
DIEKMAN JOHN DSkye Bioscience, Inc.
Diep Tuan TuSkye Bioscience, Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Skye Bioscience, Inc.Listing on record	Mar 4, 2024	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Skye Bioscience, Inc.Listing on record	Nov 6, 2023	AwardD (derivative)	14,110	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Skye Bioscience, Inc.Listing on record	Aug 29, 2023	AwardD (derivative)	1,472,692	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Skye Bioscience, Inc.Listing on record	Jan 9, 2023	AwardD (derivative)	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Skye Bioscience, Inc.Listing on record	Dec 16, 2021	AwardD (derivative)	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	OtherD (derivative)	-15,183	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	ExerciseD (derivative)	16,817	11.00 USD	$185K		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	OtherD (derivative)	-25,184	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	ExerciseD (derivative)	-15,183	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	ExerciseD (derivative)	15,183	11.00 USD	$167K		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	ExerciseD (derivative)	-8,367	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	ExerciseD (derivative)	-16,817	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	ExerciseD (derivative)	8,367	11.62 USD	$97.2K		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	Other	25,184	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	Sell	-15,183	91.00 USD	$1.4M	Unusual size	SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	Sell	-16,817	91.00 USD	$1.5M	Unusual size	SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	Other	15,183	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	Sell	-8,367	91.62 USD	$766.6K		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 1, 2019	Sell	-2,750	76.97 USD	$211.7K		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 1, 2019	ExerciseD (derivative)	4,150	11.62 USD	$48.2K		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 1, 2019	ExerciseD (derivative)	-4,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 1, 2019	OtherD (derivative)	-4,150	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 1, 2019	Sell	-1,400	76.17 USD	$106.6K		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 1, 2019	Other	4,150	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Jan 15, 2019	ExerciseD (derivative)	-8,620	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Skye Bioscience, Inc.Listing on record	Mar 4, 2024	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Skye Bioscience, Inc.Listing on record	Nov 6, 2023	AwardD (derivative)	14,110	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Skye Bioscience, Inc.Listing on record	Aug 29, 2023	AwardD (derivative)	1,472,692	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Skye Bioscience, Inc.Listing on record	Jan 9, 2023	AwardD (derivative)	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Skye Bioscience, Inc.Listing on record	Dec 16, 2021	AwardD (derivative)	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	OtherD (derivative)	-15,183	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	ExerciseD (derivative)	16,817	11.00 USD	$185K		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	OtherD (derivative)	-25,184	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	ExerciseD (derivative)	-15,183	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	ExerciseD (derivative)	15,183	11.00 USD	$167K		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	ExerciseD (derivative)	-8,367	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	ExerciseD (derivative)	-16,817	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	ExerciseD (derivative)	8,367	11.62 USD	$97.2K		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	Other	25,184	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	Sell	-15,183	91.00 USD	$1.4M	Unusual size	SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	Sell	-16,817	91.00 USD	$1.5M	Unusual size	SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	Other	15,183	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 27, 2019	Sell	-8,367	91.62 USD	$766.6K		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 1, 2019	Sell	-2,750	76.97 USD	$211.7K		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 1, 2019	ExerciseD (derivative)	4,150	11.62 USD	$48.2K		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 1, 2019	ExerciseD (derivative)	-4,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 1, 2019	OtherD (derivative)	-4,150	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 1, 2019	Sell	-1,400	76.17 USD	$106.6K		SEC
REATA PHARMACEUTICALS INCListing unverified	Feb 1, 2019	Other	4,150	—	n/a (No price was disclosed in the filing)		SEC
REATA PHARMACEUTICALS INCListing unverified	Jan 15, 2019	ExerciseD (derivative)	-8,620	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC